9th Annual Biomarkers Congress
Cardiovascular Research Technologies (CRT) 2013


Washington, District of Columbia
http://www.crtmeeting.org/default.aspx
Cardiovascular Research Technologies (CRT) 2013 will take place from February 23 - 26, 2013 in Washington DC. This year’s conference will be the most comprehensive to date. CRT 2013 has many new and exciting features, including a new, cutting-edge Valve & Structural Heart track, in addition to its standard five subject areas -- Coronary, Endovascular, Science, Technology and Nurse & Tech. Also new this year will be the Essentials of Clinical Research course as well as more exciting hands-on workshops and simulations.

Schedule of Presentations:

Saturday, February 23, 2013
06:00:00 New Presentation
06:00:00 New Presentation
18:55:00 Valve Evening Symposium | TAVR EVENING SYMPOSIUM: STARTING A TAVR PROGRAM IN YOUR INSTITUTION Augusto D. Pichard, Paul J. Corso
19:00:00 Valve Evening Symposium | Dinner and Case Presentations Ron Waksman, Augusto D. Pichard
19:15:00 Valve Evening Symposium | Aortic Stenosis: The Evolution of our Understanding of Pathophysiology and Therapeutic Modalities Robert O. Bonow
19:30:00 Valve Evening Symposium | Discussion Robert O. Bonow, Ron Waksman, Alec Vahanian, E. Murat Tuzcu, Augusto D. Pichard, Joseph Bavaria
19:40:00 Valve Evening Symposium | The Heart Team: How Does it Work for TAVR? E. Murat Tuzcu
19:55:00 Valve Evening Symposium | Discussion Robert O. Bonow, Ron Waksman, Alec Vahanian, E. Murat Tuzcu, Augusto D. Pichard, Joseph Bavaria
20:05:00 Valve Evening Symposium | How to Tailor the Optimal Treatment Modality for the Patient with AS Joseph Bavaria
20:20:00 Valve Evening Symposium | Discussion Robert O. Bonow, Ron Waksman, Alec Vahanian, E. Murat Tuzcu, Augusto D. Pichard, Joseph Bavaria
20:30:00 Valve Evening Symposium | Case in the Box Augusto D. Pichard
20:45:00 Valve Evening Symposium | Discussion Robert O. Bonow, Ron Waksman, Alec Vahanian, E. Murat Tuzcu, Augusto D. Pichard, Joseph Bavaria
20:55:00 Valve Evening Symposium | TAVR: The European experience Alec Vahanian
21:10:00 Valve Evening Symposium | Discussion Robert O. Bonow, Ron Waksman, Alec Vahanian, E. Murat Tuzcu, Augusto D. Pichard, Joseph Bavaria
21:20:00 Valve Evening Symposium | Adjourn
Sunday, February 24, 2013
03:45:00 CTO Forum | The Status of Collagenase for the Treatment of CTO Bradley H. Strauss
06:00:00 CTO Forum | Step-by-Step Review of the Retrograde Approach: Making the Connection - Reverse CART and CART Craig A. Thompson
06:00:00 CTO Forum | Complications of CTO PCI I: Ischemia - Predictors, Prevention and Management William L. Lombardi
06:00:00 New Presentation
06:00:00 Valve & Structural Heart Revolution I | My Own Experience with Mitral Clips Michael J. Mack
06:00:00 New Presentation
06:00:00 CTO Forum | Patient Selection for CTO Recanalization: What Are the Appropriate Criteria? Tarek Helmy
06:30:00 Valve & Structural Heart Revolution I | Taped Case Demonstration: Mitral Clip Procedure
06:50:00 Valve & Structural Heart Revolution I | Tips for a Successful Mitral Clip Procedure Saibal Kar
07:10:00 Valve & Structural Heart Revolution I | How Do I Treat Functional MR? The Surgeon’s Perspective Steven F. Bolling
07:20:00 Valve & Structural Heart Revolution I | Update on Maze Technique and Results
07:30:00 Valve & Structural Heart Revolution I | Is Aortic Valve Repair Superior to Replacement?
07:40:00 Valve & Structural Heart Revolution I | Panel Discussion: TBA Ted Feldman, Michael J. Mack, Saibal Kar, Steven F. Bolling, Niv Ad
07:45:00 CTO Forum | Introduction and Welcome to the CRT CTO Club: A New Beginning Craig A. Thompson, Richard R. Heuser
07:55:00 ACS & AMI Management | ANTIPLATELET CONTROVERSY FOR ACS: HOW WILL THIS iMPACT OUR PRACTICE Stephen Wiviott, Ron Waksman, David J. Cohen
07:55:00 Valve & Structural Heart Revolution I | MITRAL VALVE REPAIR Steven A. Goldstein, Niv Ad
07:55:00 CTO Forum | CTO 101: SETTING THE STAGE Craig A. Thompson, Richard R. Heuser
08:00:00 Valve & Structural Heart Revolution I | Functional Mitral Regurgitation: When to Repair – The Surgeon’s Perspective Steven F. Bolling
08:00:00 CTO Forum | Treating CTOs: Is There Enough Evidence-Based Data? Or do We Need Further Randomized Clinical Trials Gerald S. Werner
08:00:00 ACS & AMI Management | New Mechanisms and Pathogenesis of Acute Coronary Syndromes Renu Virmani
08:10:00 Valve & Structural Heart Revolution I | The Echocardiographic Subtleties and Hallmarks of Diagnosing Structural and Functional Mitral Regurgitation Steven A. Goldstein
08:10:00 CTO Forum | Indication for CTO PCI: Clinical Rationale and Appropriateness J. Aaron Grantham
08:10:00 ACS & AMI Management | Why the Third Generation Antiplatelet Agents Are Superior to First and Second Generation Paul A. Gurbel
08:20:00 Valve & Structural Heart Revolution I | Current Surgical Standards for Mitral Leaflet and Chordal Repair Thierry Georges Mesana
08:20:00 ACS & AMI Management | What Is the Standard of Care for Antiplatelet Therapy in Europe? Michael Joner
08:30:00 CTO Forum | Reduced Radiation Exposure During CTO PCI by a Gerald S. Werner
08:30:00 ACS & AMI Management | What Is the Standard of Care for Antiplatelet Therapy in the US? Jeffrey S. Berger
08:30:00 Valve & Structural Heart Revolution I | Functional Mitral Regurgitation: When to Repair – The Interventional Cardiologist’s Perspective Ted Feldman
08:40:00 CTO Forum | Wire Snaring, Externalization and More Patrick Whitlow
08:40:00 Valve & Structural Heart Revolution I | Pathology of the Mitral Valve: What You Need to Know Renu Virmani
08:40:00 ACS & AMI Management | Cost Analysis: Is it Still Cost Effective to Use Prasugrel or Ticagrelor vs. Generic Clopidogrel? David J. Cohen
08:50:00 ACS & AMI Management | The Big Antiplatelet Debate: Why I Prefer Prasugrel Over Ticagrelor Stephen Wiviott
08:50:00 Valve & Structural Heart Revolution I | The Spectrum of Evolving Mitral Repair Techniques
09:00:00 CTO Forum | How to Build Your Own CTO PCI Program Tarek Helmy
09:00:00 Valve & Structural Heart Revolution I | Degenerative MR - The Surgical Landscape: Volumes, Techniques, and Early and Late Outcomes Michael J. Mack
09:00:00 ACS & AMI Management | The Big Antiplatelet Debate: Why I Prefer Ticagrelor Over Prasugrel Paul A. Gurbel
09:10:00 ACS & AMI Management | Lessons from TRANSLATE-ACS Tracy Wang
09:10:00 CTO Forum | Live Case Demonstration from Cannizzaro Hospital, Catania, Italy Jacques J. Koolen, Barry D. Rutherford, Alfredo R. Galassi
09:10:00 Valve & Structural Heart Revolution I | MitraClip Results in Low and High Risk Degenerative MR: Emerging Data and Integrated Recommendations Peter C. Block
09:20:00 Valve & Structural Heart Revolution I | Percutaneous Approach to Mitral Valve Repair: Edge-to-Edge Mitral Leaflet Repair with the MitraClip--Technique Overview and a Taped Case Saibal Kar
09:20:00 ACS & AMI Management | How to Switch from Clopidogrel to Prasugrel or Ticagrelor
09:30:00 Valve & Structural Heart Revolution I | Know the Potential Uses and Limitations of the Mitral Clip
09:30:00 ACS & AMI Management | Lessons from TRILOGY Stephen Wiviott
09:40:00 Valve & Structural Heart Revolution I | Percutaneous Approach to Mitral Valve Repair: Mitral Valve Replacement Technology Update Howard C. Herrmann
09:40:00 ACS & AMI Management | Do We Need Prasugrel or Ticagrelor Beyond 30 Days? David J. Cohen
09:50:00 Valve & Structural Heart Revolution I | Direct Annuloplasty with Mitralign: Device Evolution, Technique and Clinical Trial Update
09:50:00 ACS & AMI Management | PAR-1 Inhibitors: What Will Be the Role of Vorapaxar for the Treatment of ACS? David J. Moliterno
10:00:00 ACS & AMI Management | Panel Discussion: Selection and Duration of Antiplatelet Therapy for Patients with ACS and AMI in 2013 Steven R. Steinhubl, Stephen Wiviott, Ron Waksman, Neal Kleiman, C. Michael Gibson, David J. Cohen
10:00:00 Valve & Structural Heart Revolution I | Panel Discussion: Is Percutaneous Valve Repair Ready for Prime Time? For Whom? Thierry Georges Mesana, Ted Feldman, Renu Virmani, Michael J. Mack, Saibal Kar, Howard C. Herrmann, Steven A. Goldstein, Steven F. Bolling, Peter C. Block
10:00:00 Break
10:05:00 CTO Forum | CTO COLLEGE: GETTING STARTED Gerald S. Werner, Craig A. Thompson
10:10:00 CTO Forum | Guiding Catheter Support Augmentation: Balloon Anchoring Techniques and Guidelines William L. Lombardi
10:15:00 Valve & Structural Heart Revolution I | Break
10:15:00 ACS & AMI Management | Break
10:20:00 CTO Forum | Anatomy of Contemporary CTO Guidewires and Selection Criteria Patrick Whitlow
10:25:00 ACS & AMI Management | ANTIPLATELET RESPONSIVENESS, GENETICS GENOMICS AND DRUG TO DRUG INTERACTIONS Paul A. Gurbel, Neal Kleiman
10:25:00 Valve & Structural Heart Revolution I | MORE MITRAL VALVE INTERVENTIONS Balram Bhargava, Peter C. Block
10:30:00 ACS & AMI Management | Does the Present Data Support Routine Platelet Responsiveness Testing? George Dangas
10:30:00 CTO Forum | Trends in Initial Guidewire Selection: For Antegrade and Retrograde Approach J. Aaron Grantham
10:30:00 Valve & Structural Heart Revolution I | Percutaneous Mitral Valve Complications and Bailout Peter C. Block
10:40:00 CTO Forum | Fundamentals of Wire Control and Evolution of the CTO Crossing Concept in Antegrade Gerald S. Werner
10:40:00 Valve & Structural Heart Revolution I | Dynamic Mitral Valve Ring Annuloplasty: The MiCardia Concept Clinical Update Maurice Buchbinder
10:40:00 ACS & AMI Management | Fibrinogen: Better Predictor of Ischemic Risk Than Platelet Reactivity? Ehtisham Mahmud
10:50:00 ACS & AMI Management | The Diabetic Patient and the Optimal Antiplatelet Therapy Dominick J. Angiolillo
10:50:00 Valve & Structural Heart Revolution I | Percutaneous Mitral Repair in High Surgical Risk Patients
11:00:00 CTO Forum | Trends in Guidewire Selection in Refractory Cases Craig A. Thompson
11:00:00 Valve & Structural Heart Revolution I | Panel Discussion: What Should Be the Optimal Approach for Mitral Valve Repair - Minimally Invasive or Median Sternotomy Percutaneous Approach? Hans R. Figulla, Peter C. Block
11:00:00 ACS & AMI Management | Genotyping: Which One Should We Perform, How to Interpret the Data and Is It Ready for Clinical Practice? Alan R Shuldiner
11:05:00 ACS & AMI Management | DEBATE: TAILORING ANITPLATELET THERAPY
11:10:00 CTO Forum | Planning the Retrograde Attack: When to Switch to Retrograde-Predictors of Success vs. Failure William L. Lombardi
11:10:00 ACS & AMI Management | We Should Tailor Antiplatelet Therapy Based on Platelet Function Testing and Genotyping Paul A. Gurbel
11:15:00 Valve & Structural Heart Revolution I | Clinical Experience with Percutaneous Mitral Repair Peter C. Block
11:20:00 ACS & AMI Management | There Is No Role for Platelet Function and Genomic Testing with the New Antiplatelet Agents Neal Kleiman
11:20:00 CTO Forum | Selection of Collateral Channel
11:25:00 Valve & Structural Heart Revolution I | Transcatheter Approaches to Prosthetic Mitral Valve Failure and Paravalvular Leaks: Tips and Tricks
11:30:00 Valve & Structural Heart Revolution I | MITRAL STENOSIS: FROM ASSESSMENT TO TREATMENT
11:30:00 ACS & AMI Management | Panel Discussion: TBA
11:30:00 CTO Forum | Contrast Awareness: Strategies to Prevent Contrast Nephropathy Roxana Mehran
11:35:00 Valve & Structural Heart Revolution I | Echocardiography of Mitral Stenosis: Severity and Important Echo Features Steven A Goldstein
11:40:00 CTO Forum | Case Presentation III Gerald S. Werner
11:40:00 ACS & AMI Management | THE ORAL FACTOR Xa INHIBITOR CONTROVERSY Manesh R. Patel, C. Michael Gibson
11:40:00 Valve & Structural Heart Revolution I | Timing of Intervention in Mitral Stenosis Ted Feldman
11:45:00 ACS & AMI Management | Did the Results of the RELY Trial Translate to Clinical Practice? C. Michael Gibson
11:50:00 Valve & Structural Heart Revolution I | How to Perform Balloon Mitral Valvuloplasty Augusto D. Pichard
11:55:00 CTO Forum | Case Presentation IV Jacques J. Koolen
11:55:00 Valve & Structural Heart Revolution I | New Surgical Aspects of MVR Thierry Georges Mesana
11:55:00 ACS & AMI Management | Rivaroxaban in Patients with ST-Elevation Myocardial Infarction: Results from ATLAS ACS 2-TIMI 51 Manesh R. Patel
12:05:00 ACS & AMI Management | How to Combine Antiplatelet Therapy with Oral Factor Xa Inhibitor Dominick J. Angiolillo
12:10:00 CTO Forum | Lunch and Visit the Exhibits and Simulators
12:10:00 Valve & Structural Heart Revolution I | Lunch and Visit the Exhibits and Simulators
12:15:00 ACS & AMI Management | Lessons from the ARISTOTLE Trial C. Michael Gibson
12:25:00 ACS & AMI Management | RUBY-1: What Is in the Future for Oral Factor Xa Inhibition in ACS? Sanjit S. Jolly
12:35:00 ACS & AMI Management | Panel Discussion: How to Choose Your Oral Factor Xa Inhibitor Sanjit S. Jolly, David J. Moliterno, Manesh R. Patel, Neal Kleiman, C. Michael Gibson, Dominick J. Angiolillo
12:50:00 ACS & AMI Management | Lunch and Visit the Exhibits and Simulators
12:55:00 Valve & Structural Heart Revolution I | AORTIC STENOSIS Michael J Reardon, Augusto D. Pichard
13:00:00 Valve & Structural Heart Revolution I | The Pathological Insight from Explanted Percutaneous Heart Valves: What Do You Need to Know Before TAVR? Renu Virmani
13:05:00 CTO Forum | CTO MASTERS: TAKING ALL COMERS Jacques J. Koolen, Barry D. Rutherford
13:10:00 CTO Forum | Guidewire Externalization J. Aaron Grantham
13:10:00 Valve & Structural Heart Revolution I | Dynamics in Patient Selection from Inoperable to Moderate Risk: TAVR vs. SAVR Alec Vahanian
13:20:00 Valve & Structural Heart Revolution I | TAVR or Surgery for Low Flow AS: Insights From the PARTNER Trial Howard C. Herrmann
13:20:00 CTO Forum | LAST (Limited Antegrade Subintimal Tracking): From Knuckle Wires to BridgePoint Craig A. Thompson
13:30:00 Valve & Structural Heart Revolution I | How TVAR Impacts Cardiac Surgery and What the Credentials for the Surgeon Should Be
13:30:00 CTO Forum | The Radial Approach for CTO PCI: Utility in the Retrograde and the Antegrade Approaches Shigeru Saito
13:35:00 ACS & AMI Management | ACUTE MI MANAGEMENT Lowell F. Satler, Jonathan S. Reiner, Alice K. Jacobs, Eric R. Bates
13:40:00 CTO Forum | Case Presentation: Retorgrade Approach Jacques J. Koolen
13:40:00 ACS & AMI Management | How to Minimize Bleeding in STEMI Patients Steven V. Manoukian
13:40:00 Valve & Structural Heart Revolution I | The Heart Valve Team: The US Experience Michael J Reardon
13:50:00 Valve & Structural Heart Revolution I | Are We Ready to Perform TAVR in Intermediate Risk Patients?
13:50:00 ACS & AMI Management | Medical Therapy for STEMI Patients During Interhospital Transport: Fibrinolytic and/or Anticoagulant? Eric R. Bates
14:00:00 ACS & AMI Management | Transradial Access for ACS, Primary PCI and Anticoagulation Considerations Daniel H. Steinberg
14:00:00 Valve & Structural Heart Revolution I | Panel Discussion: Who Should Be a Candidate for TAVR in 2013? Renu Virmani, Alec Vahanian, Michael J Reardon, Howard C. Herrmann
14:00:00 CTO Forum | Trends in CTO PCI in Europe: Update from the Euro CTO Club Gerald S. Werner
14:05:00 Valve & Structural Heart Revolution I | TRANSCATHETER AORTIC VALVE REPLACEMENT SHOW ME THE DATA Alec Vahanian, E. Murat Tuzcu
14:10:00 CTO Forum | Evolution of Strategy for the CTO PCI in the United States and Canada: An Update on Hybrid CTO PCI Richard R. Heuser
14:10:00 Valve & Structural Heart Revolution I | New Data from PARTNER E. Murat Tuzcu
14:10:00 ACS & AMI Management | New Insights into the Mortality Benefit of Bivalirudin Gregg W. Stone
14:20:00 Valve & Structural Heart Revolution I | New Data from the French Registry Alec Vahanian
14:20:00 ACS & AMI Management | Primary PCI Update from NCDR and the Action Registry Manesh R. Patel
14:30:00 Valve & Structural Heart Revolution I | Bern-Rotterdam-Munich Propensity Analysis: SVR vs. TAVR in >4000 Patients Lutz Buellesfeld
14:30:00 ACS & AMI Management | STEMI Systems of Care - Update on Mission: We Are Better, Are the Patients as Well? Alice K. Jacobs
14:40:00 ACS & AMI Management | Integrating the EMS with Hospital Primary PCI Programs: Update on the Washington DC Experience Jonathan S. Reiner
14:40:00 Valve & Structural Heart Revolution I | What Does the Future Hold for the Transapical Approach? Michael J. Mack
14:40:00 CTO Forum | Complications of CTO PCI III: Complications Unique to the Retrograde Approach
14:50:00 ACS & AMI Management | Door-In, Door-Out: Why the Delay?
14:50:00 Valve & Structural Heart Revolution I | Review of the Latest OUS Data from the CoreValve Studies
14:50:00 CTO Forum | Break
15:00:00 ACS & AMI Management | Telemedicine to Expedite Patients’ Transfer: The Cell Phone Experience Lowell F. Satler
15:00:00 Valve & Structural Heart Revolution I | Review of the Transaortic and Subclavian Approaches Michael J Reardon
15:00:00 CTO Forum | INNOVATION: WHAT'S NEXT? Gerald S. Werner, Richard R. Heuser
15:05:00 CTO Forum | Newer Methods to Facilitate the Retrograde Approach Barry D. Rutherford
15:10:00 Valve & Structural Heart Revolution I | The TAVR Valve-in-Valve Technique: Fundamentals and Clinical Results
15:10:00 ACS & AMI Management | Telemedicine to Analyze ST Segment to Detect Events Post MI C. Michael Gibson
15:15:00 CTO Forum | The Value of Multislice CT and Co-Registration for Planning and Guidance of CTO-PCI
15:20:00 ACS & AMI Management | Panel Discussion: How Should We Optimize Door-to-Balloon Time for STEMI in 2013? Gregg W. Stone, Lowell F. Satler, Jonathan S. Reiner, Manesh R. Patel, Alice K. Jacobs, C. Michael Gibson
15:20:00 Valve & Structural Heart Revolution I | Break
15:25:00 CTO Forum | Applications for Intravascular Ultrasound in Chronic Total Occlusions Barry D. Rutherford
15:30:00 Valve & Structural Heart Revolution I | UTILIZING IMAGING TECHNIQUES TO OPTIMIZE TAVI RESULTS Ron Waksman, Jeffrey J. Popma
15:35:00 ACS & AMI Management | Break
15:35:00 Valve & Structural Heart Revolution I | Optimal Techniques to Determine Valve Annulus Size Raoul Bonan
15:35:00 CTO Forum | OCT Guidance for CTO Avinger Richard R. Heuser
15:45:00 Valve & Structural Heart Revolution I | Best Techniques for Valve Positioning and Deployment
15:45:00 ACS & AMI Management | THROMBUS MANAGEMENT IN THE CATH LAB Steven V. Manoukian
15:50:00 ACS & AMI Management | INFUSE AMI: Lessons from a Mid-Sized Randomized Study Gregg W. Stone
15:55:00 CTO Forum | Most Advanced Subintimal and Re-Entry Technique Using BridgePoint Devices: Lessons from Complex Cases William L. Lombardi
15:55:00 Valve & Structural Heart Revolution I | Imaging and Quantification of Aortic Regurgitation after TAVI Lutz Buellesfeld
16:00:00 ACS & AMI Management | Thrombus Management in the Cath Lab: What are the Options and Outcomes? Sanjit S. Jolly
16:05:00 Valve & Structural Heart Revolution I | Echo Monitoring: Complications During Transcatheter Intervention for Structural Heart Disease Zuyue Wang
16:05:00 ACS & AMI Management | MYOCARDIAL PRESERVATION AND RESTORATION Steven V. Manoukian
16:05:00 CTO Forum | Adjuvant Medical Therapy for Incomplete Revascularization Giora Weisz
16:10:00 ACS & AMI Management | Translational Research for Myocardial Regeneration
16:15:00 Valve & Structural Heart Revolution I | Is Transesophageal Echo During TAVR Essential? Alec Vahanian
16:15:00 CTO Forum | Tips and Tricks for Difficult Scenarios: Long CTO, Heavily Calcified, LM Bifurcation Gerald S. Werner
16:20:00 ACS & AMI Management | Use of FFR/OCT in ACS & AMI Giulio Guagliumi
16:25:00 Valve & Structural Heart Revolution I | Taped Case Demonstration: The Balloon- Expanding Transcatheter Valve System E. Murat Tuzcu
16:25:00 CTO Forum | Live Case Demonstration from Kusatsu Heart Center, Kusatsu, Japan
16:30:00 ACS & AMI Management | How to Optimize Therapeutic Hypothermia and What to Expect Michael R. Mooney
16:40:00 ACS & AMI Management | The Use of Impella for Cardiogenic Shock Patients: Does it Save Lives?
16:45:00 Valve & Structural Heart Revolution I | Taped Case Demonstration: The Self- Expanding Transcatheter Valve System
16:50:00 ACS & AMI Management | IABP-SHOCK II: Randomized Comparison of Intra-Aortic Balloon Counterpulsation vs. Optimal Medical Therapy in Addition to Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock Manesh R. Patel
17:00:00 ACS & AMI Management | Adjourn
17:05:00 Valve & Structural Heart Revolution I | Panel Discussion: What Imaging Is Required During TAVR? Lutz Buellesfeld, Zuyue Wang, Alec Vahanian, E. Murat Tuzcu, Raoul Bonan
17:20:00 Valve & Structural Heart Revolution I | Adjourn
17:35:00 CTO Forum | Adjourn J. Aaron Grantham
18:25:00 Valve & Structural Heart Revolution I | VALVE & STRUCTURAL HEART REVOLUTION FOR THE SURGEON BREAKFAST I Niv Ad, Steven F. Bolling
Monday, February 25, 2013
06:25:00 Complex Coronary Interventions I | BASIC RADIAL ACCESS Ramon Quesada
06:30:00 Complex Coronary Interventions I | Breakfast
06:45:00 Complex Coronary Interventions I | Getting Radial Access LT and RT Saibal Kar
07:00:00 Complex Coronary Interventions I | Catheter Selection for Coronary Angiography
07:10:00 Complex Coronary Interventions I | How to Become a Superb Radialist Sunil V. Rao
07:20:00 Complex Coronary Interventions I | Anticoagulant Choices in Transradial PCI in ACS Daniel H. Steinberg
07:35:00 Complex Coronary Interventions I | Hemostasis & Radial Artery Occlusion Ramon Quesada
07:45:00 Complex Coronary Interventions I | Case Reviews Shigeru Saito
12:15:00 Complex Coronary Interventions I | LUNCHEON SYMPOSIUM: CHANGING THE LANDSCAPE OF INTERVENTION IN THE US Ron Waksman, Jeffrey J. Popma
12:20:00 Complex Coronary Interventions I | Lunch
12:45:00 Complex Coronary Interventions I | Does Second Generation DES Require A Shorter Duration of DAPT? Laura Mauri
12:55:00 Complex Coronary Interventions I | Expanding TAVR Beyond High Risk and Inoperable Patients Jeffrey J. Popma
13:05:00 Complex Coronary Interventions I | Renal Denervation Beyond Treatment of Hypertension Felix Mahfoud
13:15:00 Complex Coronary Interventions I | Drug Coated Balloons for Peripheral Artery Disease MICHAEL R. JAFF
13:25:00 Complex Coronary Interventions I | Panel Discussion Felix Mahfoud, MICHAEL R. JAFF, Ron Waksman, Jeffrey J. Popma, David E. Kandzari
13:55:00 Complex Coronary Interventions I | THE iMPACT TRIALS: SESSION I Ian T. Meredith, William Fearon, Ron Waksman, Maurice Buchbinder
14:00:00 Complex Coronary Interventions I | iMPACT Trial I
14:10:00 Complex Coronary Interventions I | iMPACT Trial II
14:20:00 Complex Coronary Interventions I | Commentary on the iMPACT Trials Session I Laura Mauri
14:30:00 Complex Coronary Interventions I | Live Case Demonstration from MedStar Washington Hospital Center, Washington, DC Lowell F. Satler, Augusto D. Pichard, Kenneth M. Kent
15:15:00 Complex Coronary Interventions I | Keynote Lecture: The Five Best Trials from 2012 that May iMPACT My Practice Gregg W. Stone
15:25:00 Complex Coronary Interventions I | Keynote Lecture What Does the Future Hold for Appropriateness, Guidelines, Reimbursement and Credentialing? David R. Holmes
15:35:00 Complex Coronary Interventions I | FFR, IVUS and OCT: Which Should We Use and When? Gary S. Mintz
15:45:00 Complex Coronary Interventions I | Lessons from FAME II and Review of the Results William Fearon
15:55:00 Complex Coronary Interventions I | Medical Therapy Should Work Well for Patients with Documented Ischemia William E. Boden
16:05:00 Complex Coronary Interventions I | The Future Is Medical Therapy: The Pipeline Is Robust Steven E Nissen
16:15:00 Complex Coronary Interventions I | Panel Discussion: How the COURAGE, FAME II and ISCHEMIA Trials Will Change Our Practice William Fearon, William E Boden, Steven E Nissen, Gary S. Mintz
16:30:00 Complex Coronary Interventions I | Live Case Demonstration from MedStar Washington Hospital Center, Washington, DC
17:15:00 Complex Coronary Interventions I | Adjourn
Tuesday, February 26, 2013
06:25:00 Complex Coronary Interventions II | ADVANCED RADIAL ACCESS Ramon Quesada
06:30:00 Complex Coronary Interventions II | Breakfast
06:45:00 Complex Coronary Interventions II | Transradial Peripheral Intervention
06:55:00 Complex Coronary Interventions II | Transradial Primary PCI Daniel H. Steinberg
07:05:00 Complex Coronary Interventions II | Transradial in Women Sunil V. Rao
07:25:00 Complex Coronary Interventions II | Treating CTO via Radial? Richard R. Heuser
07:35:00 Complex Coronary Interventions II | The Economics of Transradial Access
07:45:00 Complex Coronary Interventions II | Case Reviews Ramon Quesada
07:55:00 Complex Coronary Interventions II | COMPLEX CORONARY INTERVENTIONS Ron Waksman, Spencer B. King III
08:00:00 Complex Coronary Interventions II | Live Case Demonstration from MedStar Washington Hospital Center, Washington, DC Lowell F. Satler, Augusto D. Pichard, Kenneth M. Kent
08:30:00 Complex Coronary Interventions II | After FREEDOM and SYNTAX: Can PCI Be an Alternative to Surgery in Patients with Multivessel Disease? Spencer B. King
08:45:00 Complex Coronary Interventions II | Live Case Demonstration from Brussels University Hospital Brussels, Belgium Jacques J. Koolen, Danny Schoors
09:30:00 Complex Coronary Interventions II | How to Select Your DES: The Data-Driven Clinician’s View David A. Cox
09:40:00 Complex Coronary Interventions II | Optimal Duration of DAPT: Did We Go Too Far? Laura Mauri
09:45:00 Complex Coronary Interventions II | COMPLEX CORONARY INTERVENTIONS: COMPLEX LESION SUBSETS Jeffrey W. Moses
09:50:00 Complex Coronary Interventions II | Keynote Lecture: Unprotected Left Main: Pearls of Wisdom for Success Jeffrey W. Moses
10:00:00 Complex Coronary Interventions II | Bifurcation Management Update: Choosing the Right Strategy and Technique
10:10:00 Complex Coronary Interventions II | ISAR-LEFT MAIN 2: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents in Patients with Unprotected Left Main Disease Adnan Kastrati
10:20:00 Complex Coronary Interventions II | Panel Discussion: Is there Enough Data to Support Routine PCI for Unprotected Left Main Jeffrey W. Moses, Adnan Kastrati
10:25:00 Complex Coronary Interventions II | BRAZIL @ CRT Jeffrey W. Moses, Alexandre Abizaid
10:30:00 Complex Coronary Interventions II | Live Case Demonstration from Morristown Medical Center, Morristown, NJ Curtiss T. Stinis, Maurice Buchbinder
11:30:00 Complex Coronary Interventions II | Late-Breaking Clinical Trials and Technology from South America Alexandre Abizaid
11:40:00 Complex Coronary Interventions II | Review of Structural Heart Programs in Brazil
11:50:00 Complex Coronary Interventions II | How to Perform Successful PCI in SVG Lesions John S. Douglas
11:55:00 Complex Coronary Interventions II | IMPACT TRIALS – SESSION II Adnan Kastrati, Michael J. Cowley
12:00:00 Complex Coronary Interventions II | iMPACT Trial III
12:10:00 Complex Coronary Interventions II | iMPACT Trial IV
12:20:00 Complex Coronary Interventions II | Commentary on iMPACT Trials: Session II Adnan Kastrati
12:30:00 Complex Coronary Interventions II | Lunch and Visit the Exhibits and Simulators
14:00:00 Complex Coronary Interventions II | Live Case Demonstration from Mount Sinai Medical Center, New York, NY Samin K. Sharma
14:55:00 Complex Coronary Interventions II | PROCEDURES TO iMPACT YOUR PRACTICE Augusto D. Pichard, David A. Cox
15:00:00 Complex Coronary Interventions II | How to Perform a Safe Transseptal Augusto D. Pichard
15:10:00 Complex Coronary Interventions II | Essentials for CTO Recanalization Richard R. Heuser
15:20:00 Complex Coronary Interventions II | How to Convert Your Access to the Radial Approach Ramon Quesada
15:30:00 Complex Coronary Interventions II | Alcohol Septal Ablations Kenneth M. Kent
15:40:00 Complex Coronary Interventions II | Thrombus Management and No Reflow in the Cath Lab: Tools and Tips
15:50:00 Complex Coronary Interventions II | Cath Lab Nightmare: How to Avoid the Worst Complication John S. Douglas
16:00:00 Complex Coronary Interventions II | How to Handle a Complex Bifurcation Lesion Curtiss T. Stinis
16:10:00 Complex Coronary Interventions II | A Critical Evaluation of Bifurcation Trials & the State of our Knowledge
16:15:00 Complex Coronary Interventions II | INTERESTING CASE PRESENTATIONS Jay Giri, Rajiv Gulati
16:20:00 Complex Coronary Interventions II | Interesting Case Presentation
16:30:00 Complex Coronary Interventions II | Interesting Case Presentation
16:40:00 Complex Coronary Interventions II | Interesting Case Presentation
16:50:00 Complex Coronary Interventions II | CRT 2013 Closing Remarks Augusto D. Pichard
17:00:00 Complex Coronary Interventions II | Adjourn
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.